Analog Devices Other Income (Expense) decreased by 7.2% to -$54.85M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.5%, from -$52.02M to -$54.85M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a -11.8% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$43.71M | -$37.37M | -$255.17M | -$41.20M | -$38.92M | -$45.37M | -$54.46M | -$57.35M | -$40.46M | -$54.67M | -$62.63M | -$72.55M | -$61.52M | -$68.33M | -$53.06M | -$55.74M | -$52.02M | -$54.62M | -$58.01M | -$51.16M | -$54.85M |
| QoQ Change | — | +14.5% | -582.9% | +83.9% | +5.5% | -16.6% | -20.0% | -5.3% | +29.4% | -35.1% | -14.6% | -15.8% | +15.2% | -11.1% | +22.3% | -5.0% | +6.7% | -5.0% | -6.2% | +11.8% | -7.2% |
| YoY Change | — | — | — | — | +11.0% | -21.4% | +78.7% | -39.2% | -4.0% | -20.5% | -15.0% | -26.5% | -52.0% | -25.0% | +15.3% | +23.2% | +15.4% | +20.1% | -9.3% | +8.2% | -5.5% |
| Segment | Q2 '26 |
|---|---|
| Reportable Segment | -$54.85M |
| Total | -$54.85M |